Royalty Pharma Sub-Manager, Llc

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value

$172.8M

Q ending 2026-03-31

Prior quarter

$171.3M

Q ending 2025-12-31

Change

+0.8% QoQ

Positions

reported holdings

Largest positions

All 4 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.

Holding	Ticker	Type	Value ▼	Shares
Cytokinetics, Inc	CYTK	Shares	$64.6M	980K
Zenas Biopharma, Inc.	BCAX	Shares	$46.7M	2.4M
Biocryst Pharmaceuticals Inc	BCRX	Shares	$36.6M	3.8M
Biohaven Ltd		Shares	$24.8M	2.9M

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.